Synonyms Diabetes mellitus type 2 in obese, Diabetes mellitus type 2 in obese (disorder), NIDDM in obese + [3] |
Introduction- |
Target |
Mechanism GLP-1R modulators |
Active Org. ![]() |
Originator Org. ![]() |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target- |
Mechanism- |
Active Org. ![]() |
Originator Org. ![]() |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CB1 antagonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date01 Apr 2024 |
Sponsor / Collaborator |
Start Date01 Mar 2024 |
Sponsor / Collaborator |
Start Date13 Feb 2024 |
Sponsor / Collaborator |